Brabant Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 26

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $130M

  • Investors
  • 1

Brabant Pharma General Information

Description

Provider of pharmaceutical products. The company offers Brabafen, a low-dose fenfluramine which is for the treatment of Dravet Syndrome, a rare and catastrophic form of intractable epilepsy that begins in infancy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 74 Gartside Street
  • Manchester M3 3EL
  • England, United Kingdom
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 74 Gartside Street
  • Manchester M3 3EL
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brabant Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 27-Oct-2014 $130M Completed Generating Revenue
1. Early Stage VC 08-Mar-2013 Completed Generating Revenue
To view Brabant Pharma’s complete valuation and funding history, request access »

Brabant Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Growth Ordinary
Growth Ordinary
Ordinary
A Ordinary 17,217 $0.015314 $68.91 $68.91 1x $68.91 8.62%
A Ordinary 16,213 $0.015314 $61.26 $61.26 1x $61.26 8.12%
To view Brabant Pharma’s complete cap table history, request access »

Brabant Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brabant Pharma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aquarius Equity Partners Venture Capital Minority
To view Brabant Pharma’s complete investors history, request access »

Brabant Pharma FAQs

  • When was Brabant Pharma founded?

    Brabant Pharma was founded in 2013.

  • Where is Brabant Pharma headquartered?

    Brabant Pharma is headquartered in Manchester, United Kingdom.

  • What is the size of Brabant Pharma?

    Brabant Pharma has 26 total employees.

  • What industry is Brabant Pharma in?

    Brabant Pharma’s primary industry is Drug Delivery.

  • Is Brabant Pharma a private or public company?

    Brabant Pharma is a Private company.

  • What is the current valuation of Brabant Pharma?

    The current valuation of Brabant Pharma is .

  • What is Brabant Pharma’s current revenue?

    The current revenue for Brabant Pharma is .

  • How much funding has Brabant Pharma raised over time?

    Brabant Pharma has raised $10.5M.

  • Who are Brabant Pharma’s investors?

    Aquarius Equity Partners has invested in Brabant Pharma.

  • When was Brabant Pharma acquired?

    Brabant Pharma was acquired on 27-Oct-2014.

  • Who acquired Brabant Pharma?

    Brabant Pharma was acquired by Zogenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process